Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v3-EN
Language French English
Date Updated 2022-08-05 2022-02-08
Drug Identification Number 02404699 02404699
Brand name APO-RASAGILINE APO-RASAGILINE
Common or Proper name RASAGILINE RASAGILINE
Company Name APOTEX INC APOTEX INC
Ingredients RASAGILINE RASAGILINE
Strength(s) 1MG 1MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N04BD N04BD
ATC description DOPAMINERGIC AGENTS DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-12-13 2021-12-13
Estimated end date 2022-09-09 2022-05-20
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments